MusclePharm (OTCMKTS:MSLP) Stock Passes Below Two Hundred Day Moving Average of $0.20
MusclePharm (OTCMKTS:MSLP) Stock Passes Below Two Hundred Day Moving Average of $0.20
MusclePharm Co. (OTCMKTS:MSLP – Get Rating)'s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.20 and traded as low as $0.10. MusclePharm shares last traded at $0.10, with a volume of 23,260 shares changing hands.
在週一的交易中,MusclePharmCo.的股價跌破200日移動均線,200日移動均線切入位為0.20美元,最低交易價格為0.10美元。MusclePharm的股票最新報0.10美元,總成交量為23,260股。
MusclePharm Stock Performance
MusclePharm股票表現
The stock has a market capitalization of $3.34 million, a price-to-earnings ratio of -0.17 and a beta of 0.38. The company's 50 day moving average is $0.18 and its 200 day moving average is $0.20.
該股市值334萬美元,市盈率為-0.17,貝塔係數為0.38。該公司的50日移動均線切入位在0.18美元,200日移動均線切入位在0.20美元。
About MusclePharm
關於MusclePharm
(Get Rating)
(獲取評級)
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.
公司在美國和國際上開發、製造、營銷和分銷運動營養品和營養補充劑。該公司提供一系列高性能粉末、膠囊、片劑、凝膠和隨時可用的零食。該公司的MusclePharm品牌產品組合包括戰鬥蛋白粉和戰鬥擠壓蛋白棒;以及支鏈氨基酸、肌酸、谷氨醯胺、肉鹼、共軛亞油酸、魚油、多種維生素和其他產品等基本補充劑。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on MusclePharm (MSLP)
- Here's Why Harley-Davidson is Roaring Higher
- As Mega Caps Get Crushed, This Mid Cap Tech Stock Is Crushing It
- Why Investors Are Suddenly Excited About Vaxcyte
- Saia Stock Is Ready To Switch Gears And Move Higher
- Is The Meta Platforms Stock Meltdown a Rare Buying Opportunity?
- 免費獲取StockNews.com關於MusclePharm的研究報告(MSLP)
- 這就是為什麼哈雷-戴維森公司在咆哮
- 隨着Mega Caps被壓垮,這隻中型股科技股正在壓垮它
- 為什麼投資者突然對Vaxcell感到興奮
- SAIA股票已做好換擋走高的準備
- Meta平臺股票崩盤是難得的買入機會嗎?
Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.
接受MusclePharm日報的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊收到對MusclePharm和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。